Navigation Links
John W. Sheets Jr., Former FDA Director Of The Office Of Device Evaluation, Joins NDA Partners As Expert Consultant
Date:8/23/2017

NDA Partners Chairman Carl Peck, MD, announced today that John W. Sheets Jr., PhD, former Director of the Office of Device Evaluation at the FDA’s Center for Devices and Radiological Health and recognized leader in the medical device, pharmaceutical and biotech industries, has joined the firm as an Expert Consultant.

Prior to his FDA experience, Dr. Sheets served in senior technical leadership roles in a series of companies. He was Chief Technology Officer at Anika Therapeutics, developing biotech/regenerative medicine products. As Senior Vice President, Corporate Research at Boston Scientific, he revitalized product innovation by introducing a new biodesign process and identifying new growth markets, and as Chief Technology Officer at Ethicon (Johnson & Johnson), he created their biosurgicals platform and restructured the company’s development pipeline.

Dr. Sheets is recognized for his technical leadership in the field of ophthalmology. He was Corporate Vice President of R&D and Chief Technology Officer at Bausch and Lomb for the surgical, pharmaceutical and vision care businesses. At Alcon Laboratories, as Vice President, Surgical/IOL and Therapeutics R&D, he was responsible for surgical implants, instruments and therapeutic (drug) products used in ophthalmic surgery.

“Dr. Sheets’ knowledge and expertise of medical devices at FDA and in the Industry, in addition to his experience in the pharmaceutical and biotech industries, make him an excellent addition to NDA Partners. He will bring great value to our medical device clients and we are very pleased he has joined our team of Expert Consultants,” said Dr. Feigal, who heads NDA Partners’ Medical Device Practice.

Dr. Sheets earned his doctorate degree and a master’s degree in Material Science and Engineering, in addition to a bachelor’s degree in Zoology with a post-baccalaureate in Chemistry from the University of Florida. He also completed Harvard’s Management Development program and the Stanford University Program in Biodesign.

About NDA Partners
NDA Partners is a strategy consulting firm specializing in expert product development and regulatory advice to the medical products industry and associated service industries such as law firms, investment funds and government research agencies. The highly experienced Principals and Premier Experts of NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and virtual product development teams.

Contact
Earle Martin, Chief Executive Officer
Office: 540-738-2550
MartinEarle(at)ndapartners.com

Read the full story at http://www.prweb.com/releases/2017/08/prweb14619459.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Tough foam from tiny sheets
2. Former VP of Clinical Pharmacology at Nektar Therapeutics, Michael A. Eldon, PhD, FCP, Joins NDA Partners as Expert Consultant
3. Former Associate Director of Product Development R&D at Allergan, Melissa Kirkegaard, joins NDA Partners as Expert Consultant
4. Former Vice President of Development Operations at XenoPort, Sami Karaborni, PhD, joins NDA Partners as Expert Consultant
5. Former CEO of Eurofins Advantar Laboratories, Richard Kenley, PhD, joins NDA Partners as Expert Consultant
6. Former FDA Official to Conduct Popular ComplianceOnline Seminar on FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials
7. Former P&G VP Appointed New Industry Expert at Verixs Advisory Board
8. Former Director of FDA Division of Biostatistics, Gregory Campbell, PhD, joins NDA Partners as Expert Consultant
9. Vinod Shah, PhD, Former Senior Research Scientist in FDA Office of Pharmaceutical Sciences, Joins NDA Partners as Expert Consultant
10. Former Allergan Chief David Pyott Signs on as Special Advisor to Sienna Biopharmaceuticals
11. Dr. Daniel Spyker, Former FDA acting Deputy Division Director of Cardiovascular, Respiratory, and Neurological Devices, Joins NDA Partners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... At its national board ... Suneel I. Sheikh, the co-founder, CEO and chief research scientist of Minnesota-based Advanced ... for membership in ARCS Alumni Hall of Fame . ASTER Labs is ...
(Date:10/11/2017)... ... ... eye wash is a basic first aid supply for any work environment, but most personal ... rinse first if a dangerous substance enters both eyes? It’s one less decision, and likely ... dual eye piece. , “Whether its dirt and debris, or an acid or alkali, getting ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... today it will be hosting a Webinar titled, “Pathology is going digital. Is ... , on digital pathology adoption best practices and how Proscia improves lab economics ...
(Date:10/11/2017)... ROTTERDAM, the Netherlands and LAGUNA HILLS, ... that The Institute of Cancer Research, London ... will use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify ... high-risk trial known as MUK nine . The University ... this trial, which is partly funded by Myeloma UK, and ...
Breaking Biology Technology:
(Date:5/16/2017)... 16, 2017   Bridge Patient Portal , ... MD EMR Systems , an electronic medical ... GE, have established a partnership to build an ... the GE Centricity™ products, including Centricity Practice Solution ... These new integrations will allow healthcare delivery ...
(Date:4/17/2017)... MELBOURNE, Florida , April 17, 2017 ... security technology company, announces the filing of its 2016 Annual Report ... Securities and Exchange Commission. ... Report on Form 10-K is available in the Investor Relations section ... well as on the SEC,s website at http://www.sec.gov . ...
(Date:4/11/2017)... April 11, 2017 No two people ... at the New York University Tandon School of ... have found that partial similarities between prints are ... in mobile phones and other electronic devices can ... The vulnerability lies in the fact that fingerprint-based ...
Breaking Biology News(10 mins):